Jump to content
RemedySpot.com

Mistletoe & Ariad CML trial

Rate this topic


Guest guest

Recommended Posts

Healing with mistletoe is used in Europe to treat cancer. The FDA however does

not approve this treatment because it has not proved its efficacy. There are

some websites that are promoting the use of mistletoe and we should remember the

slogan Caveat emptor or buyer beware. Just passing this along in case you have

questions about its overall safety. Mistletoe by the way, is a semiparasitic

plant that grows on several types of trees, including apple, oak, maple, elm,

pine, and birch. It has also gained usage for other ailments such as arthritis

and infertility. My words.

" Mistletoe is one of the most widely studied complementary and alternative

medicine therapies for cancer. In certain European countries, products made from

European mistletoe are among the most prescribed therapies for cancer patients. "

" Very few bad side effects have been reported from the use of mistletoe extract,

though mistletoe plants and berries are poisonous to humans. The U.S. Food and

Drug Administration (FDA) has not approved mistletoe as a treatment for cancer

or any other medical condition. The FDA does not allow injectable mistletoe to

be imported, sold, or used except for clinical research. "

http://www.cancer.gov/cancertopics/pdq/cam/mistletoe/Patient/allpages/print

FYI,

Lottie Duthu

" Enlighten the people generally, and tyranny and oppressions of body

and mind will vanish like evil spirits at the dawn of the day. "

by: Jefferson

_______________________________

_______________________________

The initial findings from this study show AP24534 to be well-tolerated and to

produce beneficial anti-leukemia activity in patients who have failed prior

tyrosine kinase inhibitor therapy for CML,” stated Cortes, M.D., professor

and deputy chair, Department of Leukemia, M.D. Cancer Center and the

study’s principal investigator. “Pending further clinical trials, AP24534

appears to represent a potential significant advance for CML patients who have

become resistant or refractory to currently available therapies and who are in

great need of new treatment options.”

http://www.news-medical.net/news/20091208/Positive-data-from-ARIAD-Pharmaceutica\

ls-ongoing-AP24534-study-in-advanced-hematological-cancer-patients.aspx

We have several members who are in this trial. Perhaps you would like to share

your own experience, positive and negative. This is the trial I am waiting for,

but I have the opportunity to get into the DCC 2036 trial and need to make a

decision. I know other members would be interested to know as well.

Thanx,

Lottie Duthu

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...